{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T08:04:56Z","timestamp":1751875496734,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:00:00Z","timestamp":1619654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:00:00Z","timestamp":1619654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100002037","name":"CSL Behring Foundation for Research and Advancement of Patient Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002037","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00296-021-04871-x","type":"journal-article","created":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T05:33:46Z","timestamp":1619674426000},"page":"1273-1280","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunoglobulin deficiencies in treated patients suffering from rheumatoid arthritis"],"prefix":"10.1007","volume":"41","author":[{"given":"Sara","family":"Kaestner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Juergen","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Braeuer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kaestner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,29]]},"reference":[{"issue":"9285","key":"4871_CR1","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/s0140-6736(01)06075-5","volume":"358","author":"DM Lee","year":"2001","unstructured":"Lee DM, Weinblatt ME (2001) Rheumatoid arthritis. Lancet 358(9285):903\u2013911. https:\/\/doi.org\/10.1016\/s0140-6736(01)06075-5","journal-title":"Lancet"},{"key":"4871_CR2","unstructured":"Classen M, Diehl V, Kochsiek K, Hallek M, B\u00f6hm M, Schmiegel W (2009) Innere Medizin. Elsevier"},{"issue":"6","key":"4871_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/ard.56.6.351","volume":"56","author":"K Aho","year":"1997","unstructured":"Aho K, Heliovaara M, Knekt P, Reunanen A, Aromaa A, Leino A, Kurki P, Heikkila R, Palosuo T (1997) Serum immunoglobulins and the risk of rheumatoid arthritis. Ann Rheum Dis 56(6):351\u2013356","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"4871_CR4","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1002\/art.10524","volume":"46","author":"MF Doran","year":"2002","unstructured":"Doran MF, Crowson CS, Pond GR, O\u2019Fallon WM, Gabriel SE (2002) Frequency of infection in patients with rheumatoid arthritis compared with controls: A population-based study. Arthritis Rheum 46(9):2287\u20132293. https:\/\/doi.org\/10.1002\/art.10524","journal-title":"Arthritis Rheum"},{"issue":"9","key":"4871_CR5","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1002\/art.10529","volume":"46","author":"MF Doran","year":"2002","unstructured":"Doran MF, Crowson CS, Pond GR, O\u2019Fallon WM, Gabriel SE (2002) Predictors of infection in rheumatoid arthritis. Arthritis Rheum 46(9):2294\u20132300. https:\/\/doi.org\/10.1002\/art.10529","journal-title":"Arthritis Rheum"},{"issue":"11","key":"4871_CR6","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1136\/ard.2011.151043","volume":"70","author":"A Strangfeld","year":"2011","unstructured":"Strangfeld A, Eveslage M, Schneider M, Bergerhausen HJ, Klopsch T, Zink A, Listing J (2011) Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient? Ann Rheum Dis 70(11):1914\u20131920. https:\/\/doi.org\/10.1136\/ard.2011.151043","journal-title":"Ann Rheum Dis"},{"key":"4871_CR7","first-page":"331","volume":"13","author":"JP Leddy","year":"1970","unstructured":"Leddy JP, Deitchman J, Bakemeier RF (1970) IgG subclasses measurement of radioimmunoassay in normal and hypogammaglobulinaemic sera. Arthritis Rheum 13:331\u2013332","journal-title":"Arthritis Rheum"},{"issue":"1\u20132","key":"4871_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0022-1759(75)90077-0","volume":"8","author":"F Shakib","year":"1975","unstructured":"Shakib F, Stanworth DR, Drew R, Catty D (1975) A quantitative study of the distribution of IgG sub-classes in a group of normal human sera. J Immunol Methods 8(1\u20132):17\u201328","journal-title":"J Immunol Methods"},{"issue":"3","key":"4871_CR9","first-page":"501","volume":"21","author":"M van der Giessen","year":"1975","unstructured":"van der Giessen M, Rossouw E, van Veen TA, van Loghem E, Zegers BJ, Sander PC (1975) Quantification of IgG subclasses in sera of normal adults and healthy children between 4 and 12 years of age. Clin Exp Immunol 21(3):501\u2013509","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"4871_CR10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1699-0463.1978.tb02567.x","volume":"86C","author":"VA Oxelius","year":"1978","unstructured":"Oxelius VA (1978) Crossed immunoelectrophoresis and electroimmunoassay of human IgG subclasses. Acta pathologica et microbiologica Scandinavica Section C, Immunology 86C(3):109\u2013116","journal-title":"Acta pathologica et microbiologica Scandinavica Section C, Immunology"},{"issue":"2","key":"4871_CR11","first-page":"473","volume":"56","author":"MA French","year":"1984","unstructured":"French MA, Harrison G (1984) Serum IgG subclass concentrations in healthy adults: a study using monoclonal antisera. Clin Exp Immunol 56(2):473\u2013475","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"4871_CR12","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/clinchem\/34.7.1407","volume":"34","author":"JV Madassery","year":"1988","unstructured":"Madassery JV, Kwon OH, Lee SY, Nahm MH (1988) IgG2 subclass deficiency: IgG subclass assays and IgG2 concentrations among 8015 blood donors. Clin Chem 34(7):1407\u20131413","journal-title":"Clin Chem"},{"issue":"11","key":"4871_CR13","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1373\/clinchem.2003.022350","volume":"49","author":"U Schauer","year":"2003","unstructured":"Schauer U, Stemberg F, Rieger CH, Borte M, Schubert S, Riedel F, Herz U, Renz H, Wick M, Carr-Smith HD, Bradwell AR, Herzog W (2003) IgG subclass concentrations in certified reference material 470 and reference values for children and adults determined with the binding site reagents. Clin Chem 49(11):1924\u20131929","journal-title":"Clin Chem"},{"issue":"5","key":"4871_CR14","first-page":"472","volume":"23","author":"F Liu","year":"2003","unstructured":"Liu F, Wang Q, Qiu YR, Li MM (2003) Analysis of the relation between serum immunoglobulin and auto-antibody levels in patients with rheumatoid. Acad J First Med Coll PLA 23(5):472\u2013473","journal-title":"Acad J First Med Coll PLA"},{"issue":"1","key":"4871_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pupt.2009.08.001","volume":"23","author":"P Chanez","year":"2010","unstructured":"Chanez P, Burge PS, Dahl R, Creemers J, Chuchalin A, Lamarca R, Garcia Gil E (2010) Aclidinium bromide provides long-acting bronchodilation in patients with COPD. Pulm Pharmacol Ther 23(1):15\u201321. https:\/\/doi.org\/10.1016\/j.pupt.2009.08.001","journal-title":"Pulm Pharmacol Ther"},{"issue":"3","key":"4871_CR16","first-page":"338","volume":"72","author":"C Neumann","year":"2013","unstructured":"Neumann C, Proft F, Hammitzsch A, Gruenke M, Schulze-Koops H (2013) Hypogammaglobulinemia is a frequent finding in patients under immunosuppressive therapy but does not correlate with susceptibility to infections. Ann Rheum Dis 72(3):338","journal-title":"Ann Rheum Dis"},{"key":"4871_CR17","unstructured":"Deutsche Gesellschaft f\u00fcr Rheumatologie (2012) German guidelines for the sequential medical treatment of rheumatoid arthritis 2012: adapted EULAR recommendations and update of a treatment algorithm. AWMF-Register Nr 060\/004"},{"issue":"1","key":"4871_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/art.10727","volume":"48","author":"M Bukhari","year":"2003","unstructured":"Bukhari M, Wiles N, Lunt M, Harrison B, Scott D, Symmons D, Silman A (2003) Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: results from a large observational inception study. Arthr Rheumatol 48(1):46\u201353","journal-title":"Arthr Rheumatol"},{"issue":"9","key":"4871_CR19","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Menard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsky J, Wolfe F, Hawker G (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62(9):2569\u20132581. https:\/\/doi.org\/10.1002\/art.27584","journal-title":"Arthritis Rheum"},{"issue":"3","key":"4871_CR20","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1136\/jcp.46.3.198","volume":"46","author":"B Bull","year":"1993","unstructured":"Bull B, Caswell M, Ernst E, Jou J, Kallner A, Koepke J, Lewis S, Lowe G, Rampling M, Stuart J (1993) ICSH recommendations for measurement of erythrocyte sedimentation-rate. J Clin Pathol 46(3):198\u2013203","journal-title":"J Clin Pathol"},{"issue":"1","key":"4871_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van \u2019t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL, (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis and rheumatism 38(1):44\u201348","journal-title":"Arthritis and rheumatism"},{"issue":"6","key":"4871_CR22","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/ard.2007.084459","volume":"68","author":"G Wells","year":"2009","unstructured":"Wells G, Becker JC, Teng J, Dougados M, Schiff M, Smolen J, Aletaha D, van Riel PL (2009) Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis 68(6):954\u2013960. https:\/\/doi.org\/10.1136\/ard.2007.084459","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4871_CR23","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/art.1780100308","volume":"10","author":"J Barden","year":"1967","unstructured":"Barden J, Mullinax F, Waller M (1967) Immunoglobulin levels in rheumatoid arthritis: comparison with rheumatoid factor titers, clinical stage and disease duration. Arthritis Rheum 10(3):228\u2013234","journal-title":"Arthritis Rheum"},{"issue":"5","key":"4871_CR24","first-page":"850","volume":"67","author":"H Claman","year":"1966","unstructured":"Claman H, Merrill D (1966) Serum immunoglobulins in rheumatoid arthritis. J Lab Clin Med 67(5):850\u2013854","journal-title":"J Lab Clin Med"},{"issue":"5","key":"4871_CR25","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1136\/ard.26.5.412","volume":"26","author":"R Marcolongo","year":"1967","unstructured":"Marcolongo R, Carcassi A, Frullini F, Bianco G, Bravi A (1967) Levels of serum immunoglobulins in patients with rheumatoid arthritis. Ann Rheum Dis 26(5):412\u2013418","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4871_CR26","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1136\/ard.27.5.431","volume":"27","author":"E Veys","year":"1968","unstructured":"Veys E, Claessens H (1968) Serum levels of IgG, IgM, and IgA in rheumatoid arthritis. Ann Rheum Dis 27(5):431","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"4871_CR27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1258\/000456303763046067","volume":"40","author":"R Lock","year":"2003","unstructured":"Lock R, Unsworth D (2003) Immunoglobulins and immunoglobulin subclasses in the elderly. Ann Clin Biochem 40(2):143\u2013148","journal-title":"Ann Clin Biochem"},{"issue":"1","key":"4871_CR28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1365-2249.2007.03545.x","volume":"151","author":"A Gonzalez-Quintela","year":"2008","unstructured":"Gonzalez-Quintela A, Alende R, Gude F, Campos J, Rey J, Meijide L, Fernandez-Merino C, Vidal C (2008) Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clin Exp Immunol 151(1):42\u201350","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"4871_CR29","doi-asserted-by":"publisher","first-page":"R170","DOI":"10.1186\/ar3923","volume":"14","author":"C Roseman","year":"2012","unstructured":"Roseman C, Truedsson L, Kapetanovic MC (2012) The effect of smoking and alcohol consumption on markers of systemic inflammation, immunoglobulin levels and immune response following pneumococcal vaccination in patients with arthritis. Arthritis Res Ther 14(4):R170","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"4871_CR30","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJM197009172831205","volume":"283","author":"PH Schur","year":"1970","unstructured":"Schur PH, Borel H, Gelfand EW, Alper CA, Rosen FS (1970) Selective gamma-G globulin deficiencies in patients with recurrent pyogenic infections. N Engl J Med 283(12):631\u2013634","journal-title":"N Engl J Med"},{"key":"4871_CR31","unstructured":"Schmidt R, Baumann U (2011) Humorale Immundefekte. Prim\u00e4re und Sekund\u00e4re Imundefekte. Uni-Med, 3. neubearb. Auflage 2011. ."},{"issue":"9","key":"4871_CR32","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1002\/art.27555","volume":"62","author":"JE Gottenberg","year":"2010","unstructured":"Gottenberg JE, Ravaud P, Bardin T, Cacoub P, Cantagrel A, Combe B, Dougados M, Flipo R, Godeau B, Guillevin L (2010) Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry. Arthr Rheumatol 62(9):2625\u20132632","journal-title":"Arthr Rheumatol"},{"issue":"Suppl 3","key":"4871_CR33","doi-asserted-by":"publisher","first-page":"A888","DOI":"10.1136\/annrheumdis-2013-eular.2654","volume":"72","author":"S Shaffu","year":"2013","unstructured":"Shaffu S, Royle J, Neame R (2013) AB0332 Rituximab & immunoglobulin level monitoring in rheumatoid arthritis\u2013a clinical audit. Ann Rheum Dis 72(Suppl 3):A888\u2013A889","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4871_CR34","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3899\/jrheum.090856","volume":"37","author":"RF Van Vollenhoven","year":"2010","unstructured":"Van Vollenhoven RF, Emery P, Bingham CO, Keystone EC, Fleischmann R, Furst DE, Macey K, Sweetser M, Kelman A, Rao R (2010) Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trials. J Rheumatol 37(3):558\u2013567","journal-title":"J Rheumatol"},{"issue":"6","key":"4871_CR35","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1136\/ard.2010.144998","volume":"70","author":"MH Buch","year":"2011","unstructured":"Buch MH, Smolen JS, Betteridge N, Breedveld FC, Burmester G, D\u00f6rner T, Ferraccioli G, Gottenberg J-E, Isaacs J, Kvien TK (2011) Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis 70(6):909\u2013920","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4871_CR36","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1093\/rheumatology\/ker417","volume":"51","author":"I De La Torre","year":"2012","unstructured":"De La Torre I, Leandro MJ, Valor L, Becerra E, Edwards JC, Cambridge G (2012) Total serum immunoglobulin levels in patients with RA after multiple B-cell depletion cycles based on rituximab: relationship with B-cell kinetics. Rheumatology 51(5):833\u2013840","journal-title":"Rheumatology"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04871-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-021-04871-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04871-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T23:13:54Z","timestamp":1698966834000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-021-04871-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,29]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["4871"],"URL":"https:\/\/doi.org\/10.1007\/s00296-021-04871-x","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"type":"print","value":"0172-8172"},{"type":"electronic","value":"1437-160X"}],"subject":[],"published":{"date-parts":[[2021,4,29]]},"assertion":[{"value":"30 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Complaince with ethical standards"}},{"value":"None of the authors has any conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/competing interests"}},{"value":"The study was approved by the local ethics committee (2927\u201309\/10).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants signed a written informed consent before their data were included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors consented to the publication of this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}